MEDTRONIC PERFORMER TM CPB, MODEL R51, PCPB

K052555 · Rand S.R.L. · DTQ · Mar 15, 2006 · Cardiovascular

Device Facts

Record IDK052555
Device NameMEDTRONIC PERFORMER TM CPB, MODEL R51, PCPB
ApplicantRand S.R.L.
Product CodeDTQ · Cardiovascular
Decision DateMar 15, 2006
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 870.4220
Device ClassClass 2
AttributesTherapeutic

Intended Use

The Medtronic Performer CPB Advanced Extracorporeal Circulatory Support System is indicated for use up to 6 hours in the extracorporeal circulation of fluids for cardiopulmonary bypass procedures, when used by a qualified medical professional who is experienced in the operation of this or similar equipment. The centrifugal pump is indicated for use in pumping blood through an extracorporeal perfusion circuit for extracorporeal circulatory support for periods appropriate to cardiopulmonary bypass (up to six hours).

Device Story

Performer CPB is a heart-lung machine console integrating cardiopulmonary bypass functions into a compact, vertically-oriented, collapsible instrument. It processes inputs from integrated sensors, including SatO2/Hct, temperature, and cardioplegia air detectors. The system features roller pumps with unidirectional rotation and emergency handcranks, an active air removal system with arterial flow servo control, and a built-in printer. Operated by perfusionists in clinical settings, the device provides real-time parameter trending and alerts via an icon-based GUI, audio/voice tones, and independent status-colored LEDs. Data recording and software updates are managed via an integrated memory card. The system optimizes extracorporeal volume and provides feedback-controlled pump stops for safety. It benefits patients by providing precise, monitored circulatory support during bypass procedures.

Clinical Evidence

Bench testing only. Performance data provided for air handling, blood trauma, and cardioplegia delivery. Software verification and validation completed. No clinical trial data presented.

Technological Characteristics

Heart-lung machine console with vertical orientation for volume reduction. Features: roller pumps, integrated active air removal, SatO2/Hct/temperature monitoring, cardioplegia air detector with pump stop, and memory card interface. Connectivity: integrated GUI, printer, and LED status indicators. Software-controlled monitoring and servo-control of arterial flow.

Indications for Use

Indicated for patients requiring cardiopulmonary bypass or extracorporeal circulatory support for up to 6 hours. Must be operated by qualified medical professionals experienced in perfusion equipment.

Regulatory Classification

Identification

A cardiopulmonary bypass heart-lung machine console is a device that consists of a control panel and the electrical power and control circuitry for a heart-lung machine. The console is designed to interface with the basic units used in a gas exchange system, including the pumps, oxygenator, and heat exchanger.

Predicate Devices

Reference Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ MAR 1 5 2006 Medtronic Performer CPB 510(k) Submission # APPENDIX I 05 2555 page 1 of 3 ### 510(k) Summary ### Medtronic Performer CPB System (As required by 21CFR 807.92) #### A. Submitter Information B. | Submitter's Name: | RanD S.r.l. | |---------------------------|-----------------------------------------------| | Address: | Via Sparato, 60<br>41036 Medolla (MO) – ITALY | | Telephone Number: | 763.391.9533 (for contact) | | Contact Person: | Preeti Jain | | Date Submission Prepared: | September 15, 2005 | Device Information | Trade Name | Performer Cardiopulmonary Bypass System | |-------------------------------------|------------------------------------------------------------------------------------| | Common Name | Cardiopulmonary bypass heart-lung machine console | | Address of Manufacturing Facilities | Manufacturing Site<br>RanD S.r.l.<br>Via Sparato, 60<br>41036 Medolla (MO) – ITALY | | | Establishment Registration Number<br>Pending | | FDA Classification | Class II | | FDA Product Classification Code | DTQ | | FDA Regulation Number | 21 CFR 870.4220 | | FDA Classification Panel | Cardiovascular | ### Predicate Devices: - COBE Century Perfusion Pump (K960974) . - Terumo Advanced Perfusion System 1 (K022947) . ## The Performer CPB has incorporated capabilities from five stand alone Medtronic devices which are: - Medtronic Resting Heart System (K031700) . {1}------------------------------------------------ Image /page/1/Picture/0 description: The image shows the text "Medtronic Performer CPB 510(k) Submission" on the left side of the image. On the right side of the image, the text "K052555" and "page dof 3" are written in a handwritten font. The text on the left side of the image is written in a more formal font. The image appears to be a page from a document. - Medtronic 560 BioConsuole System (K051303) . - Medtronic Oxygen Saturation and Hematocrit System (K954501) . - CSS Cardioplegia Safety System (K973237) . - Medtronic Pressure Display Box and Tubing Set (K852232) . ### Device Description: The Performer CPB, is a next generation heart lung machine that integrates the primary functions and safety features needed to perform cardiopulmonary bypass and related circulatory support procedures. along with enhanced user conveniences, into a reduced sized instrument. The product is designed and manufactured by RanD S.r.l., Medolla, Italy for Medtronic and exclusively distributed by Medtronic Perfusion Systems. It's initial configuration and features are optimized for use with the Medtronic Resting Heart System (K03170). The key differences between the competitive heart lung machines and the Performer CPB arc: - . A small foot print for the machine and pump's layout optimized (vertical orientation) for extracorporcal volume reduction. Collapsible feature for storage and easy transportation. - . Electrically adjustable height and stability system. - . Integrated Active Air Removal System. - . A built in printer. - Pre configured roller pump rotation . (unidirectional) and built in Handcrank in roller pumps for emergencies. - . Integrated "Memory Card" for treatment data recording and software updates. - . Integrated SatO2/Hct and Tcmperature monitoring system. - . Cardioplegia delivery air detector with pump stop feed back. - Selectable alcrt/alarm tones (including voice). . - . Active Air removal with arterial flow servo control. - . Predominant 'icon' based GUI. - Independent status colored LED system (traffic . light style) for alerts and alarms in addition to the audio and visual set ups on the actual user interface screen. {2}------------------------------------------------ Medtronic Performer CPB 510(k) Submission - Roller pump cover sensors. - . . Real time integrated parameters' trending. Indications for Use: The Medtronic Performer CPB Advanced Extracorporeal Circulatory Support System is indicated for use up to 6 hours in the extracorporeal circulation of fluids for cardiopulmonary bypass procedures, when used by a qualified medical professional who is experienced in the operation of this or similar equipment. The centrifugal pump is indicated for use in pumping blood through an extracorporeal perfusion circuit for extracorporeal circulatory support for periods appropriate to cardiopulmonary bypass (up to six hours). #### C. Comparison of Required Technological Characteristics Medtronic Performer CPB System is a system comprised of standard components of an extracorporeal circuit for use during cardiopulmonary circulatory support. The system has the same technological characteristics as a traditional circuit and the single components have the same technological characteristics as the predicate. #### D. Performance Data Performance data, such as, air handling capabilities, blood trauma, cardioplegia delivery have been provided in the 510(k) submission to show equivalence of the Medtronic Performer CPB System, when working with Resting Heart Disposable Module to COBE Century System and other referenced devices. In addition comprehensive testing has been completed on the machine including performance and Software Verification and Validation. #### E. Conclusion Medtronic Performer CPB System is substantially equivalent to the noted predicate devices based on the similarities of technological characteristics, indications for use and the results of performance comparative testing and is safe and effective for its intended use. {3}------------------------------------------------ Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 MAR 1 5 2006 Rand S.R.L. c/o Ms. Preeti Jain Director, Regulatory/Clinical Affairs 7611 Northland Drive Minneapolis, MN 55428 Re: K052555 Performer CPB Heart Lung Machine Regulation Number: 21 CFR 870.4220 Regulation Name: Cardiopulmonary Bypass Heart Lung Machine Console Regulatory Class: Class II (Two) Product Code: DTQ Dated: March 3, 2006 Received: March 6, 2006 Dear Ms. Jain: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, Fi)A may publish further announcements concerning your device in the Federal Register. {4}------------------------------------------------ Page 2 - Ms. Preeti Jain Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html. Sincerely vours, Bhummar for Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {5}------------------------------------------------ ## Appendix II ## Indications for Use 510(k) Number (if known): 05d555 Device Name: Indications For Use: The Medtronic Performer CPB Advanced Extracorporeal Circulatory Support System is indicated for use up to 6 hours in the extracorporeal circulation of fluids for cardiopulmonary bypass procedures, when used by a qualified medical professional who is experienced in the operation of this or similar equipment. The centrifugal pump is indicated for use in pumping blood through an extracorporeal perfusion circuit for extracorporeal circulatory support for periods appropriate to cardiopulmonary bypass (up to six hours). Over-The-Counter Use _________________________________________________________________________________________________________________________________________________________ Prescription Use X AND/OR (Part 21 CFR 801 Subpart D) 510(k) Number KO50555 (21 CFR 807 Subpart C) ## (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) | Concurrence of CDRH, Office of Device Evaluation (ODE) | | |---------------------------------------------------------|-------------| | <div> <img alt="Signature" src="signature.png"/> </div> | | | (Division Sign-Off) | Page 1 of 1 | | Division of Cardiovascular Devices | | Confidential
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%